The U.S. & Canada Skin Cancer Dermatology Market size is expected to reach USD 3,395.97 million By 2030, registering a CAGR of 5.5%, according to a new report by Grand View Research, Inc. Technological advancements and increasing prevalence of skin cancer are anticipated to fuel the growth.
The growing usage of smartphones and the development
of smartphone compatible dermatoscopes are the factors anticipated to fuel the
market growth. According to the Canadian Radio-television and
Telecommunications Commission data, the percentage of Canadians using a
smartphone increased from 73% in 2015 to 78% in 2017, thus indicating high
potential for teledermatology in the country.
In addition, ongoing research activities for
advancements in the dermatology field are anticipated to drive the growth of
the market in U.S and Canada. For instance, according to the study published by
Nature Journal, Deep Convolutional Neural Networks (CNN) classified the various
skin cancers with a competence level comparable to a dermatologist, thus
highlighting the potential of Artificial Intelligence (AI) in the field of
dermatology.
Inappropriate use of ABCD criteria by Medical
necessity auditors is one of the major concerns of dermatologists. For
instance, some of the melanoma positive biopsies have been ruled as ‘medically
unnecessary’ due to lack of medical documentation of ABCD or signs and
symptoms. The ABCD tool was primarily designed for public education and not an
important aspect of the physician’s note.
Related Press Release@ U.S. & Canada Skin Cancer Dermatology Market Report
U.S. & Canada Skin Cancer
Dermatology Market Report Highlights
- Skin biopsy is the most widely used test for skin cancer and thus,
accounted for the largest market share in 2019
- Diagnostic imaging is anticipated to witness rapid growth over the
forecast period due to the introduction of advanced imaging and
non-invasive diagnostic techniques
- The 40-59 segment held the largest market share in 2019 while the
20-39 segment is anticipated to witness lucrative growth over the forecast
period
- Teledermatology programs such as DermaGO, ACCESSDERM are anticipated
to improve patient access in the U.S. and Canada
- Hospital OPD segment held a significant share of the U.S. and
Canada skin cancer dermatology market in 2019 owing to the presence of
public insurance systems is expected to enhance the patient influx in this
setting
- Age and gender of the dermatologists significantly affect the type
of practice, practice location and work hours.
- Some of the key market players are Firefly; SkinIO, Canfield
Scientific, Inc., FotoFinder Systems, Inc., 3Gen, MetaOptima, Agilent
Technologies, SkinVision, Speclipse, Inc., Skin Analytics.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment